GlobalRPh RX List - ZUBSOLV
- Product / population
- ZUBSOLV sublingual combination; supporting study used IV buprenorphine alone.
- Renal measure
- Dialysis-dependent renal failure; pharmacokinetic evidence only.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
The cited renal study found similar buprenorphine pharmacokinetics in dialysis-dependent and control participants after an IV buprenorphine dose. The effects of renal failure on naloxone pharmacokinetics are unknown. This is not a direct renal-dose trial of the sublingual fixed combination and supplies no numeric adjustment schedule. Do not equate a single-component IV observation with proven unchanged exposure to both components.